Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by Stuatoron Jul 11, 2017 3:28am
214 Views
Post# 26454111

RE:RE:Combination with BLVD?

RE:RE:Combination with BLVD?40 cents?...  Nothing but incompetence here.  

Total General & Administrative Expenses: 4,248,355. That's G&A for last year. Or just slightly less than 5.5M, which is cash on hand (after removing short term liabilities).  1M was due to terranova so 3.2M.

Total consideration paid 9,072,259 for RBP Healthcare.  The acquisition generated revenue of 565,206 in 5 months.  Paying > 6.5 times sales.  But in its June 29, 2016 release it stated that it had contracts in place to produce up to 3M/year is revenue.  Edward Brann was part of this deal and it a terrible acquisition.

This company is in a death spiral.  The only ones not too oblviously to see that, are the ones calling for the company to liquidate.  If the company doesn't liquidate, it's hitting <0.06/share which is approximately the cash on hand after removing this year's G&A's expense.  
 

 





Bullboard Posts